These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18508288)

  • 1. Advanced glycation end products in senile diabetic and nondiabetic patients with cataract.
    Gul A; Rahman MA; Salim A; Simjee SU
    J Diabetes Complications; 2009; 23(5):343-8. PubMed ID: 18508288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could oxidative stress associate with age products in cataractogenesis?
    Gul A; Rahman MA; Hasnain SN; Salim A; Simjee SU
    Curr Eye Res; 2008 Aug; 33(8):669-75. PubMed ID: 18696342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of fructose concentration on cataractogenesis in senile diabetic and non-diabetic patients.
    Gul A; Rahman MA; Hasnain SN
    Graefes Arch Clin Exp Ophthalmol; 2009 Jun; 247(6):809-14. PubMed ID: 19198870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications.
    Gul A; Rahman MA; Salim A; Simjee SU
    Age (Dordr); 2008 Dec; 30(4):303-9. PubMed ID: 19424854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant status in diabetic and non-diabetic senile patients, with cataract or cardiovascular complications.
    Gul A; Rahman MA
    Saudi Med J; 2008 Feb; 29(2):179-84. PubMed ID: 18246223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation endproducts in human diabetic and non-diabetic cataractous lenses.
    Pokupec R; Kalauz M; Turk N; Turk Z
    Graefes Arch Clin Exp Ophthalmol; 2003 May; 241(5):378-84. PubMed ID: 12698254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of cytokines and AGE products in diabetic and non-diabetic patients with cataract.
    Hamid S; Gul A; Hamid Q
    Int J Health Sci (Qassim); 2016 Oct; 10(4):507-515. PubMed ID: 27833515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in glycosylated proteins in diabetic and non-diabetic patients with and without cardiovascular complications.
    Gul A; Rahman MA
    Asia Pac J Clin Nutr; 2003; 12(3):277-81. PubMed ID: 14505990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of serum biomarkers in nutritional disorders: glycated apolipoprotein B, fasting serum glucose, fructosamine, stable and labile glycated hemoglobin in diabetic and non-diabetic subjects.
    De Michele G; Correale M; De Michele O; Guerra V; Mazzarelli R; Misciagna G
    Immunopharmacol Immunotoxicol; 2008; 30(4):925-36. PubMed ID: 18720163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentosidine and N-carboxymethyl-lysine: biomarkers for type 2 diabetic retinopathy.
    Ghanem AA; Elewa A; Arafa LF
    Eur J Ophthalmol; 2011; 21(1):48-54. PubMed ID: 20544678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycation of human lens proteins from diabetic and (nondiabetic) senile cataract patients.
    Duhaiman AS
    Glycoconj J; 1995 Oct; 12(5):618-21. PubMed ID: 8595250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant markers in human senile and diabetic cataractous lenses.
    Hashim Z; Zarina S
    J Coll Physicians Surg Pak; 2006 Oct; 16(10):637-40. PubMed ID: 17007750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes.
    Aso Y; Inukai T; Tayama K; Takemura Y
    Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products in human diabetic lens capsules.
    Rankenberg J; Rakete S; Wagner BD; Patnaik JL; Henning C; Lynch A; Glomb MA; Nagaraj RH
    Exp Eye Res; 2021 Sep; 210():108704. PubMed ID: 34302851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of serum fructosamine as a measure of glycemia in young and old diabetic and non-diabetic subjects.
    Negoro H; Morley JE; Rosenthal MJ
    Am J Med; 1988 Sep; 85(3):360-4. PubMed ID: 3414731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients.
    Takeuchi M; Makita Z; Yanagisawa K; Kameda Y; Koike T
    Mol Med; 1999 Jun; 5(6):393-405. PubMed ID: 10415164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction.
    Koga K; Yamagishi S; Okamoto T; Inagaki Y; Amano S; Takeuchi M; Makita Z
    Int J Clin Pharmacol Res; 2002; 22(1):13-7. PubMed ID: 12395914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control.
    Turk Z; Mesić R; Benko B
    Clin Chim Acta; 1998 Oct; 277(2):159-70. PubMed ID: 9853699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.